ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Fresita Proteins Ltd reported revenue from operations of ₹0.8 Cr (-81.4% YoY) and net profit of ₹0.1 Cr (-75.0% YoY) for Q2 FY27.
Fresita Proteins fixed a Rs. 89.76 Crore rights issue at Rs. 120 per share, record date October 30, 2026. Issue closes November 26, 2026.
Fresita Proteins intimated a Rights Issue Committee meeting on October 26, 2026, to finalize its ₹90 Crore rights issue terms. No decisions have been made yet.
Fresita Proteins Limited concluded its 35th Annual General Meeting on September 30, 2026. Shareholders transacted five resolutions, including approval for borrowing and investment limits of ₹1,000 Crore each.
Sarda Proteins Limited responded to a BSE query regarding recent stock price movement. The company stated the fluctuations are driven by market forces and conditions.
Sarda Proteins Limited has changed its name to Fresita Proteins Limited, effective September 21, 2026. The name change received approval from the Ministry of Corporate Affairs and BSE.
Sarda Proteins Limited filed its 35th Annual Report for the financial year ended 31st March 2026 with the stock exchange.
Sarda Proteins set its 35th AGM for September 30, 2026, with book closure September 24–30. E-voting cut-off date is September 23, 2026.
Sarda Proteins board approved convening its AGM on September 30, 2026, along with e-voting, scrutinizer, and register-closure arrangements. No financial or operational decisions were taken.
Sarda Proteins Limited has scheduled a board meeting for September 7, 2026. The agenda includes approval for the upcoming Annual General Meeting and associated administrative matters.